Uncontrolled, open Phase IIa study to investigate efficacy and safety of efalizumab in patients with moderate to severe palmoplantar pustular psoriasis (PPP).
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2012
At a glance
- Drugs Efalizumab (Primary)
- Indications Palmoplantar pustulosis
- Focus Therapeutic Use
- 09 Aug 2011 New trial record